％0期刊论文％A Olsson的，克伦M.％A Wiedenroth，克里斯托弗B.％A坎普，扬克里斯托弗％A Breithecker，安德烈亚斯％A夫格，扬％A克隆巴赫，加布里埃尔A.％A哈斯，Moritz的％A哈姆，基督教％A Kramm，和Thorsten％A古斯，斯蒂芬％A Ghofrani，侯赛因Ardeschir％A辛瑞契扬B.％A Cebotari，Serghei％A迈耶，卡特琳％A Hoeper被Marius M.％A迈耶，埃克哈德％A Liebetrau，克里斯托弗％A迈耶，不能手术的患者的慢性血栓栓塞性肺动脉高血压哈德C.％T球囊血管成形术肺：初始德国经验％d 2017％R 10.1183 / 13993003.02409-2016％Ĵ欧洲呼吸杂志％P 1602409％V 49％N6％X球囊血管成形术肺动脉（BPA）是治疗不能手术的慢性血栓栓塞性肺动脉高压（CTEPH）。我们报告的前瞻性一系列连续56例谁在两个德国经历了266 BPA干预（中位数，百分之五的患者）的治疗出现机构。All patients underwent a comprehensive diagnostic work-up including right heart catheterisation at baseline and 24 weeks after their last intervention.BPA resulted in improvements in WHO functional class, 6 min walk distance (mean change, +33 m), right ventricular function and haemodynamics, including a decline in mean pulmonary artery pressure by 18% and in pulmonary vascular resistance by 26%. Procedure-related adverse events occurred in 9.4% of the interventions. The most common complications were related to pulmonary vascular injury and consecutive pulmonary bleeding. Most of these events were asymptomatic and self-limiting, but one patient died from pulmonary bleeding, resulting in a mortality rate of 1.8%.BPA resulted in haemodynamic and clinical improvements but was also associated with a considerable number of complications, including one fatal pulmonary bleeding. As the effects of BPA on survival are unknown, randomised controlled outcome trials comparing BPA with approved medical therapies in patients with inoperable CTEPH are required to allow for appropriate risk–benefit assessments.BPA improves haemodynamics and exercise capacity in patients with inoperable CTEPH but complications are not uncommon http://ow.ly/mMYY30b1rch %U //www.qdcxjkg.com/content/erj/49/6/1602409.full.pdf